SCHEMBL2676358

SCHEMBL2676358

CC(C)CN1CCN(Cc2c(C(=O)O)c3cccc(Cl)c3c(=O)n2-c2ccccc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 6/20 0.39
PIK3CG P48736 4/20 0.39
HTR7 P34969 2/20 0.38
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 2/20 0.35
SHMT2 P34897 1/20 0.35
REN P00797 1/20 0.35
SLC2A1 P11166 1/20 0.35
PIK3R1 P27986 3/20 0.35
PIK3R2 O00459 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
USP2 O75604 1/20 0.34
MCL1 Q07820 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
SLC6A4 P31645 1/20 0.34
NOX4 Q9NPH5 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2676829 0.90 PIK3CD (0.40) PIK3CDPIK3CGHTR7KDM4EALDH1A1
SCHEMBL2676908 0.87 NPSR1 (0.42) HTR7KDM4EALDH1A1MAPTSHMT2
SCHEMBL2676203 0.86 PIK3CD (0.37) PIK3CDPIK3CGHTR7KDM4EALDH1A1
SCHEMBL1717863 0.85 TACR3 (0.44) PIK3CDPIK3CGPIK3R1PIK3R2
SCHEMBL2677225 0.84 DRD2 (0.38) HTR7KDM4EALDH1A1REN
SCHEMBL2675246 0.82 REN (0.44) MAPTRENMEN1KMT2A
SCHEMBL2676121 0.80 REN (0.43) REN
SCHEMBL2676125 0.80 REN (0.43) REN
SCHEMBL2675783 0.79 MAPT (0.39) HTR7KDM4EALDH1A1MAPTMEN1
SCHEMBL1717911 0.79 MAPK1 (0.39) KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173639-B2 Isoquinolinone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2012-05-08 US claimed
US-20090143402-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2009-06-04 US claimed
US-8173639-B2 Isoquinolinone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2012-05-08 US disclosed
US-20090143402-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143402-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS KCNQ3, KCNK3, GRIK3 PIK3CD 2379/4885PIK3CG 2438/4885HTR7 598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.